Therapy Resistant Arterial Hypertension
Conditions
Brief summary
This trial is designed to establish invasive and non-invasive measures of arterial stiffness as potential predictors of treatment response to renal sympathetic denervation
Detailed description
Regardless of the ongoing debate on the general effect of renal sympathetic denervation in therapy resistant hypertension, all trials published so far face the problem of a certain proportion of nonresponders to treatment. Previous data shows, that to some extent this might be attributable to arterial stiffening. Elevated invasive pulse wave velocity as an established marker for arterial stiffness has been found to be associated with nonresponse to renal denervation treatment in a smaller trial population. This trial attempts to assess the predictive value of different invasive and non-invasive markers for arterial stiffness in an adequately powered population.
Interventions
DEVICERenal sympathetic denervation (RDN)
Catheter based renal sympathetic denervation for therapy resistant arterial hypertension
Sponsors
Heart Center Leipzig - University Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patients with therapy resistant arterial hypertension (\>=3 antihypertensive drugs including at least one diuretic without any dosage change in the preceding 4 weeks) and office BP \>160 mmHg systolic or 90 mmHg diastolic
Exclusion criteria
* average systolic daytime BP \<135 mmHg in 24h ambulatory blood pressure measurement (ABPM) * pregnancy * known renal artery stenosis * \>= 1 renal artery diameter \< 4 mm * life expectancy \<6 months * participation in any other clinical trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Predictive value of invasive Pulse wave velocity for blood pressure response after renal denervation | 3 Months | difference in daytime blood pressure (ABPM) between patients with low (\<14.4 m/s) vs. high invasive pulse wave velocity |
| Predictive value of noninvasive and invasive measures of arterial stiffness (Pulse wave velocity assessed invasively, with a piezoelectric device and MRI-based) in combination with clinical variables | 3 Months | AUC of ROCs for noninvasive and invasive measures of arterial stiffness in predicting blood pressure response to renal denervation |
Secondary
| Measure | Time frame |
|---|---|
| Predictive value of MRI-assessed aortic distensibility on Change in daytime ambulatory blood pressure | 3 months, 6 months, 12 months |
| Predictive value of MRI-assessed aortic distensibility on Change in 24 h ambulatory blood pressure | 3 months, 6 months, 12 months |
| Change in 24h ambulatory blood pressure | 3 months, 6 months, 12 months |
| Predictive value of MRI-assessed total arterial compliance on Change in 24 h ambulatory blood pressure | 3 months, 6 months, 12 months |
| comparison of predictive value of invasive pulse wave velocity, invasive central pulse pressure, noninvasive pulse wave velocity, noninvasive central pulse pressure, aortic distensibility, total arterial compliance for Change in ambulatory blood pressure | 3 months, 6 months, 12 months |
| Predictive value of MRI-assessed total arterial compliance on Change in daytime ambulatory blood pressure | 3 months, 6 months, 12 months |
| Change in exercise blood pressure | 3 months |
Countries
Germany
Outcome results
None listed